Yuri Maricich

CIK: 0001881045

Transaction Breakdown

Open Market Buys (P)2 (40.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAMP

Camp4 Therapeutics Corp

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

CAMP
Camp4 Therapeutics Corp
Aug 3, 2026
Purchase(P)
Direct
6.6K shares at avg. $1.65$11K
CAMP
Camp4 Therapeutics Corp
Apr 1, 2026
Award(A)
Stock Option (Right to Buy)
Direct
215K shares-
CAMP
Camp4 Therapeutics Corp
Dec 11, 2025
Award(A)
Stock Option (Right to Buy)
Direct
190K shares-
CAMP
Camp4 Therapeutics Corp
Sep 11, 2025
Purchase(P)
Direct
6.1K shares at avg. $1.65$10K
CAMP
Camp4 Therapeutics Corp
Apr 1, 2025
Award(A)
Stock Option (Right to Buy)
Direct
80K shares-

		Type	Shares	Price		Ownership
Aug 3, 2026	CAMP Camp4 Therapeutics Corp	Purchase(P)	6,551	$1.65	$10,809	Direct
Apr 1, 2026	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	215,000	-	-	Direct
Dec 11, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	190,000	-	-	Direct
Sep 11, 2025	CAMP Camp4 Therapeutics Corp	Purchase(P)	6,060	$1.65	$9,999	Direct
Apr 1, 2025	CAMP Camp4 Therapeutics Corp	Award(A) Stock Option (Right to Buy)	80,000	-	-	Direct

1-5 of 5 transactions

About Maricich Yuri

Maricich Yuri (SEC CIK 0001881045) files insider reports with the SEC as Chief Medical Officer of Camp4 Therapeutics Corp (CAMP).

Signal8 holds 6 ownership filings by Maricich Yuri (1 Form 3, 5 Form 4), filed between Oct 10, 2024 and Aug 5, 2026. Those filings report 5 transactions, from Apr 1, 2025 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Maricich Yuri's filings is in CAMBRIDGE, MA.

Recent filings by Maricich Yuri

Aug 3, 2026: Open-market purchase of CAMP shares (Form 4, code P).
Apr 1, 2026: Grant or award of CAMP derivative securities (Form 4, code A).
Dec 11, 2025: Grant or award of CAMP derivative securities (Form 4, code A).
Sep 11, 2025: Open-market purchase of CAMP shares (Form 4, code P).
Apr 1, 2025: Grant or award of CAMP derivative securities (Form 4, code A).

Other insiders filing for Camp4 Therapeutics Corp (CAMP)

Gold Kelly, Chief Financial Officer
Schwab Andrew J., Director
Tardiff Daniel, Chief Scientific Officer
5AM Partners VI, LLC, 10% Owner
Young Richard A, Director
Mandel-Brehm Josh, Chief Executive Officer

How to read Form 4 transaction codes